15% Umjovo we-Amoxicillin

15% Isithombe Esifakiwe Somjovo we-Amoxicillin

Incazelo emfushane:

Ukubukeka:Izinhlayiya ezinhle ezixubile, zicwila ngemva kokuma, ziba ingxube emhlophe emhlophe ngemva kokuzamazama.

Izinkomba:Ukutheleleka kwebhaktheriya e-gram-positive kanye ne-gram-negative bacteria.

Ukuphatha:Umjovo we-Intramuscular

Izinyathelo zokuzivikela:
1.Shake kahle ngaphambi kokusebenzisa.
2.Akukho ngaphezu kuka-20 ml endaweni yomjovo.

Imali yokuthengisa ye FOB	US $0.5 – 9,999 / Ucezu
Inani elincane le-oda	1 Ucezu/Izingcezu
Supply Amandla	10000 Ucezu/Izingcezu Ngenyanga
Isikhathi sokukhokha	T/T, D/P, D/A, L/C

Thumela i-imeyili kithi

Imininingwane Yomkhiqizo

Iphrofayela Yenkampani

Omaka bomkhiqizo

Inkomba

Umjovo we-Amoxicillinukumiswa kwezinhlayiya ezinhle.Ngemva kokuma, izinhlayiya ezinhle ziyacwila futhi zibe ukumiswa okumhlophe okufana nombala ngemva kokuzamazama.[Isenzo se-Pharmacological] I-Amoxicillin ivimbela ukuhlanganiswa kwezindonga zamangqamuzana ebhaktheriya, ukuze amagciwane asesigabeni sokukhula abe ama-spheroids kanye nokuqhekeka kanye nama-lyse bacteria.Ilungele i-Streptococcus ehlukahlukene, i-penicillinase engakhiqizi i-Staphylococcus, i-Clostridium namanye amagciwane e-Gram-positive, kanye ne-Pasteurella, i-Mannheimia hemolyticus, i-Escherichia coli, i-Salmonella namanye amagciwane angenayo i-Gram-negative.Umsebenzi we-antibacterial.

Ngemuva komjovo we-intramuscular ezingulubeni nasezinkomeni, i-bioavailability ingu-60% kuya ku-100%, futhi ukugxila okuphezulu kwe-plasma okungu-1.5 kuya ku-4.5 µg/ml kufinyelelwa emahoreni angu-1 kuya kwangu-3 ngemva komjovo.Ngemuva kokuthi izingulube nezinkomo zijovwe ngalo mkhiqizo, ukugcwala kwezidakamizwa egazini ngaphezu kwe-MIC90 kwagcinwa amahora angama-36 namahora angama-72, ngokulandelana.Ngemuva kwemijovo ephindaphindiwe (amahora angu-48 phakathi kwemijovo emibili), imingcele ye-pharmacokinetic izinzile futhi awukho umphumela wokuqongelela.Ikhishwa ikakhulukazi ngezinso ngendlela esebenzayo.
Ukusebenzisana kwezidakamizwa I-Macrolides, i-sulfonamides kanye nama-tetracycline ama-antibiotic avimbela ukuhlanganiswa kwamaprotheni ebhaktheriya.Ukusetshenziswa kanyekanye kwalawa ma-antibiotic kunganciphisa umphumela we-bactericidal we-amoxicillin.
Izinkomba: Isetshenziselwa ukutheleleka kwamagciwane e-gram-positive kanye namagciwane e-gram-negative abangelwa amagciwane azwela i-amoxicillin ezingulubeni nasezinkomeni.

Umthamo kanye nokuphatha

Ibalwa njenge-amoxicillin.Umjovo we-Intramuscular: umthamo owodwa, 15 mg wengulube nezinkomo ngekhilogremu ngayinye yesisindo somzimba.Omunye umjovo unganikezwa ngemva kwamahora angu-48 uma kudingeka.

Izinyathelo zokuzivikela

(1)15% umjovo we-AmoxicillinI-contraindicated ezilwaneni ezingezwani nama-penicillin.
(2) I-contraindicated ezilwaneni ezithintekile ezinokwehluleka okukhulu kwezinso.
(3) Nyakazisa kahle ngaphambi kokusetshenziswa.
(4) Angabi ngaphezu kwama-20 ml endaweni yomjovo.

Ukusabela okubi

Ukuphathwa kwalo mkhiqizo kungase kuholele ezenzweni zokungezwani komzimba nezinto ezithile, futhi ngezinye izikhathi kube nokungezwani okunamandla (okufana nokushaqeka kwe-anaphylactic).

Isikhathi sokuhoxa

Izinsuku eziyi-16 zezinkomo, izinsuku ezingama-20 ezingulubeni kanye nezinsuku ezi-3 zokuzila.

Isitoreji

Ivalwe futhi igcinwe endaweni epholile.

Okwedlule: 30% Florfenicol Injection

Olandelayo: Umjovo we-Analgin 30%.

I-Hebei Veyong Pharmaceutical Co., Ltd, yasungulwa ngo-2002, etholakala eShijiazhuang City, eSifundazweni saseHebei, eChina, eduze kweNhloko-dolobha yaseBeijing.Uyibhizinisi elikhulu lemithi yezilwane eqinisekiswe yi-GMP, ene-R&D, ukukhiqizwa nokudayiswa kwama-API wezilwane, amalungiselelo, okuphakelayo okuxutshwe ngaphambili nezithasiselo zokudla.NjengeSikhungo Sezobuchwepheshe Sesifundazwe, i-Veyong isungule uhlelo olusha lwe-R&D lomuthi omusha wezilwane, futhi iyibhizinisi lezobuchwepheshe elaziwa kuzwelonke elisekelwe kudokotela wezilwane, kunochwepheshe abangama-65.I-Veyong inezisekelo ezimbili zokukhiqiza: i-Shijiazhuang ne-Ordos, lapho isisekelo se-Shijiazhuang sihlanganisa indawo engu-78,706 m2, nemikhiqizo ye-API engu-13 ehlanganisa i-Ivermectin, i-Eprinomectin, i-Tiamulin Fumarate, i-Oxytetracycline hydrochloride ects, kanye ne-11, imigqa yokukhiqiza ye-powder yokulungiselela , premix, bolus, izibulala-zinambuzane nesibulala-magciwane, njll.I-Veyong ihlinzeka ngama-API, amalungiselelo angaphezu kwe-100 elebula uqobo, kanye nesevisi ye-OEM & ODM.

I-Veyong ibheka ukubaluleka okukhulu ekuphathweni kohlelo lwe-EHS(Imvelo, Impilo Nokuphepha), futhi yathola izitifiketi ze-ISO14001 ne-OHSAS18001.I-Veyong isohlwini lwamasu amabhizinisi ezimboni asafufusa esifundazweni sase-Hebei futhi ingaqinisekisa ukuhlinzekwa okuqhubekayo kwemikhiqizo.

I-Veyong yasungula uhlelo oluphelele lokuphatha ikhwalithi, yathola isitifiketi se-ISO9001, isitifiketi se-China GMP, isitifiketi se-APVMA GMP yase-Australia, isitifiketi se-Ethiopia GMP, isitifiketi se-Ivermectin CEP, futhi yaphumelela ukuhlolwa kwe-US FDA.I-Veyong inethimba elichwepheshile lokubhalisa, ukuthengisa kanye nenkonzo yezobuchwepheshe, inkampani yethu ithole ukwethenjwa nokusekelwa kumakhasimende amaningi ngekhwalithi yomkhiqizo omuhle kakhulu, ikhwalithi ephezulu yokuthengisa kwangaphambili kanye nenkonzo yangemuva kokuthengisa, ukuphathwa okungathi sína nokwesayensi.I-Veyong yenze ukubambisana kwesikhathi eside namabhizinisi amaningi emithi yezilwane aziwa emhlabeni wonke ngemikhiqizo ethunyelwa eYurophu, eNingizimu Melika, eMpumalanga Ephakathi, e-Afrika, e-Asia, njll. emazweni nasezifundeni ezingaphezu kuka-60.